SCHEMBL29636853

SCHEMBL29636853

Nc1cc(C2CCN(C3CCNCC3)CC2)nc2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 4/20 0.42
POLB P06746 1/20 0.41
ACHE P22303 1/20 0.40
KMT2A Q03164 2/20 0.40
HPGD P15428 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
BMPR1B O00238 1/20 0.40
BMPR1A P36894 1/20 0.40
ACVR1B P36896 1/20 0.40
TGFBR1 P36897 1/20 0.40
ACVR1 Q04771 1/20 0.40
HTR3A P46098 1/20 0.40
KHK P50053 4/20 0.39
PARP1 P09874 1/20 0.39
MEN1 O00255 1/20 0.39
HRH4 Q9H3N8 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HTT P42858 1/20 0.39
OPRM1 P35372 1/20 0.39
OPRD1 P41143 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30998387 0.87 HRH4 (0.50) NCF1POLBACHEKMT2AHPGD
Hydrochloric Acid SCHEMBL29862942 0.86 KMT2A (0.49) NCF1POLBACHEKMT2AHPGD
SCHEMBL29636637 0.85 HTR3A (0.51) NCF1POLBACHEKMT2AHPGD
SCHEMBL29636762 0.82 NCF1 (0.38) NCF1POLBACHEKMT2AHPGD
SCHEMBL31677954 0.73 POLB (0.49) NCF1POLBACHEHPGDSMN1; SMN2
SCHEMBL24288997 0.71 KMT2A (0.42) KMT2AHPGDSMN1; SMN2BMPR1BBMPR1A
Hydrochloric Acid SCHEMBL29862880 0.70 KMT2A (0.46) POLBACHEKMT2AHPGDHTR3A
SCHEMBL25361079 0.69 PARP1 (0.61) KHKPARP1
SCHEMBL27866891 0.68 NCF1 (0.69) NCF1ACHEKMT2AHPGDHTR3A
Hydrochloric Acid SCHEMBL28834209 0.67 HRH4 (0.46) KMT2AMEN1HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4017492-A1 MOLECULES THAT BIND TO TDP-43 FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND RELATED DISORDERS Biohaven Therapeutics Ltd. (US) 2022-06-29 EP disclosed